Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age
Background - Few antihypertensive drugs are available in appropriate formulations for infants. - Method - We investigated candesartan cilexetil liquid suspension in a 4-week, randomized double-blind dose-ranging study followed by a 1-year open-label treatment phase (N...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2010
|
| In: |
Journal of hypertension
Year: 2010, Volume: 28, Issue: 5, Pages: 1083-1090 |
| ISSN: | 1473-5598 |
| DOI: | 10.1097/HJH.0b013e328336b86b |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/HJH.0b013e328336b86b Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/jhypertension/Fulltext/2010/05000/Efficacy,_safety_and_pharmacokinetics_of.28.aspx 
|
| Author Notes: | Franz Schaefer, Johan van de Walle, Aleksandra Zurowska, Charlotte Gimpel, Koen van Hoeck, Dorota Drozdz, Giovanni Montini, Ingretta V. Bagdasorova, Jonathan Sorof, Jennifer Sugg, Renli Teng, James W. Hainer, for the Candesartan in Children with Hypertension (CINCH) Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1855012073 | ||
| 003 | DE-627 | ||
| 005 | 20240329080215.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230809s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/HJH.0b013e328336b86b |2 doi | |
| 035 | |a (DE-627)1855012073 | ||
| 035 | |a (DE-599)KXP1855012073 | ||
| 035 | |a (OCoLC)1425874231 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schaefer, Franz |d 1961- |e VerfasserIn |0 (DE-588)1023365383 |0 (DE-627)718365577 |0 (DE-576)366705598 |4 aut | |
| 245 | 1 | 0 | |a Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age |c Franz Schaefer, Johan van de Walle, Aleksandra Zurowska, Charlotte Gimpel, Koen van Hoeck, Dorota Drozdz, Giovanni Montini, Ingretta V. Bagdasorova, Jonathan Sorof, Jennifer Sugg, Renli Teng, James W. Hainer, for the Candesartan in Children with Hypertension (CINCH) Investigators |
| 264 | 1 | |c 2010 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.08.2023 | ||
| 520 | |a Background - Few antihypertensive drugs are available in appropriate formulations for infants. - Method - We investigated candesartan cilexetil liquid suspension in a 4-week, randomized double-blind dose-ranging study followed by a 1-year open-label treatment phase (NCT00244621). The drug was administered at 0.05, 0.2 or 0.4 mg/kg per day in 93 hypertensive children aged 1-5 years, of whom 74 had underlying renal disorders. - Results - A single-dose pharmacokinetic profile was obtained in 10 patients. At 4 weeks, SBP declined dose dependently by 6, 9 and 12 mmHg in the three dose groups (P = 0.01), and DBP by 5, 8 and 11 mmHg (P = 0.03). During the 1-year follow-up, responder rates (both SBP and DBP < 95th percentile) ranged from 48.2 to 54.1%. Candesartan lowered the blood pressure regardless of age, sex, BMI or cause of hypertension. The pharmacokinetic profile was independent of age, sex and weight, and was similar to that in older children and adults. In participants with proteinuric renal disease (urinary albumin/creatinine ratio >30 mg/g), a 57% median decline in albumin/creatinine ratio was observed at 4 weeks, which was dose related (P = 0.007) and persisted with long-term administration. There were no notable electrocardiographic or laboratory abnormalities. A mild decline in estimated glomerular filtration rate observed at 4 weeks was not progressive with long-term dosing. Candesartan was generally well tolerated; two patients withdrew for adverse events (fatigue and worsening glomerulopathy). One patient died, probably from acute-on-chronic renal failure. - Conclusion - Candesartan cilexetil dose-dependently decreases blood pressure and albuminuria in hypertensive infants and is generally well tolerated. | ||
| 700 | 1 | |a Walle, Johan van de |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zurowska, Aleksandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gimpel, Charlotte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hoeck, Koen van |e VerfasserIn |4 aut | |
| 700 | 1 | |a Drozdz, Dorota |e VerfasserIn |4 aut | |
| 700 | 1 | |a Montini, Giovanni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bagdasorova, Ingretta V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sorof, Jonathan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sugg, Jennifer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teng, Renli |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hainer, James W. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of hypertension |d London : Lippincott, Williams & Wilkins, 1983 |g 28(2010), 5, Seite 1083-1090 |h Online-Ressource |w (DE-627)320581373 |w (DE-600)2017684-3 |w (DE-576)091014018 |x 1473-5598 |7 nnas |a Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age |
| 773 | 1 | 8 | |g volume:28 |g year:2010 |g number:5 |g pages:1083-1090 |g extent:8 |a Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age |
| 856 | 4 | 0 | |u https://doi.org/10.1097/HJH.0b013e328336b86b |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/jhypertension/Fulltext/2010/05000/Efficacy,_safety_and_pharmacokinetics_of.28.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230809 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1023365383 |a Schaefer, Franz |m 1023365383:Schaefer, Franz |d 910000 |d 910500 |d 50000 |e 910000PS1023365383 |e 910500PS1023365383 |e 50000PS1023365383 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1855012073 |e 4364171859 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age","title":"Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"title_sort":"Journal of hypertension","subtitle":"official journal of International Society of Hypertension, European Society of Hypertension","title":"Journal of hypertension"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"28(2010), 5, Seite 1083-1090","volume":"28","year":"2010","pages":"1083-1090","issue":"5","extent":"8"},"language":["eng"],"pubHistory":["1.1983 -"],"note":["Gesehen am 27.11.20","Ungezählte Beil.: Suppl"],"origin":[{"publisher":"Lippincott, Williams & Wilkins","dateIssuedKey":"1983","publisherPlace":"London","dateIssuedDisp":"1983-"}],"disp":"Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of ageJournal of hypertension","type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1473-5598"],"eki":["320581373"],"zdb":["2017684-3"]},"recId":"320581373"}],"person":[{"role":"aut","family":"Schaefer","display":"Schaefer, Franz","given":"Franz"},{"given":"Johan van de","role":"aut","family":"Walle","display":"Walle, Johan van de"},{"role":"aut","family":"Zurowska","display":"Zurowska, Aleksandra","given":"Aleksandra"},{"display":"Gimpel, Charlotte","family":"Gimpel","role":"aut","given":"Charlotte"},{"given":"Koen van","display":"Hoeck, Koen van","role":"aut","family":"Hoeck"},{"given":"Dorota","display":"Drozdz, Dorota","family":"Drozdz","role":"aut"},{"role":"aut","family":"Montini","display":"Montini, Giovanni","given":"Giovanni"},{"given":"Ingretta V.","family":"Bagdasorova","role":"aut","display":"Bagdasorova, Ingretta V."},{"display":"Sorof, Jonathan","role":"aut","family":"Sorof","given":"Jonathan"},{"given":"Jennifer","role":"aut","family":"Sugg","display":"Sugg, Jennifer"},{"given":"Renli","family":"Teng","role":"aut","display":"Teng, Renli"},{"given":"James W.","display":"Hainer, James W.","family":"Hainer","role":"aut"}],"language":["eng"],"note":["Gesehen am 09.08.2023"],"origin":[{"dateIssuedDisp":"2010","dateIssuedKey":"2010"}],"name":{"displayForm":["Franz Schaefer, Johan van de Walle, Aleksandra Zurowska, Charlotte Gimpel, Koen van Hoeck, Dorota Drozdz, Giovanni Montini, Ingretta V. Bagdasorova, Jonathan Sorof, Jennifer Sugg, Renli Teng, James W. Hainer, for the Candesartan in Children with Hypertension (CINCH) Investigators"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1855012073"],"doi":["10.1097/HJH.0b013e328336b86b"]},"recId":"1855012073"} | ||
| SRT | |a SCHAEFERFREFFICACYSA2010 | ||